COMMUNIQUÉS West-GlobeNewswire
-
Le KFSH de Riyad obtient la distinction « Global Elite Five-Star » de Davos Healthcare et figure parmi les 5 % des hôpitaux les mieux évalués au monde
06/11/2026 -
TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12
06/11/2026 -
MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)
06/11/2026 -
IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer
06/11/2026 -
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
06/11/2026 -
Minerva Neurosciences Provides Third Quarter 2026 Financial Results and Business Updates
06/11/2026 -
Immunocore reports third quarter financial results and provides a business update
06/11/2026 -
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
06/11/2026 -
Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
06/11/2026 -
Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week's Inaugural 2026 Awards
06/11/2026 -
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
06/11/2026 -
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
06/11/2026 -
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026 -
Regenerative Ophthalmology Takes Center Stage This November 7 at the Next Generation Medicine Congress 2026 in Dubai
06/11/2026 -
Notice of Annual General Meeting 2026
06/11/2026 -
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026 -
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
06/11/2026 -
Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
06/11/2026 -
Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones
06/11/2026
Pages